Ajit Johnson

Indian-born cancer geneticist

  • University College London
  • University of Edinburgh
Known for
  • Computational Biology
  • Bioinformatics
  • Oncogenomics
Scientific careerInstitutionsHarvard University, Dana–Farber Cancer Institute Websitewww.ajitjohnson.com

Ajit Johnson Nirmal is a cancer geneticist. He has also campaigned to raise awareness on tech addiction and net neutrality.[1][2]

Education

Born in Vellore, Johnson graduated with a bachelor's degree in biotechnology at Karunya University. Johnson graduated from University College London in 2011 and worked at the Indian Institute of Science. He earned a Doctor of Philosophy in cancer genetics and genomics from the University of Edinburgh[3] and performed his post-doctoral work at Harvard Medical School and Dana Farber Cancer Institute.[4]

Career

Research

Johnson and colleagues developed a cell based gene therapy for haemophilia patients at the National Cancer Centre Singapore.[5][6] Johnson developed ImSig, a network-based computational framework that facilitates the characterization of immune cells within the tumor microenvironment.[7] Johnson's work involves multi-dimensional characterization (genetic, transcriptional, spatial and biophysical attributes) of the tumor ecosystem [8] and understanding the differences in molecular signature of immune cells [9] across tumours.

References

  1. ^ Cashin, Declan. "These Posters Perfectly Sum Up Twentysomethings' Addiction to the Internet". BuzzFeed.
  2. ^ Bulkley, McKenna. "The Truth About #ThisGeneration". www.huffingtonpost.com.
  3. ^ Nirmal, Ajit Johnson (28 September 2018). "British Library Thesis Collection". University of Edinburgh.
  4. ^ Nirmal, Ajit Johnson. "Harvard Scholar- Ajit Johnson Nirmal".
  5. ^ Sivalingam, Jaichandran; Kenanov, Dimitar; Han, Hao; Nirmal, Ajit Johnson; Ng, Wai Har; Lee, Sze Sing; Masilamani, Jeyakumar; Phan, Toan Thang; Maurer-Stroh, Sebastian; Kon, Oi Lian (1 March 2016). "Multidimensional Genome-wide Analyses Show Accurate FVIII Integration by ZFN in Primary Human Cells". Molecular Therapy. 24 (3): 607–619. doi:10.1038/mt.2015.223. ISSN 1525-0016. PMC 4786920. PMID 26689265.
  6. ^ Lee, Sze Sing; Sivalingam, Jaichandran; Nirmal, Ajit J.; Ng, Wai Har; Kee, Irene; Song, In Chin; Kiong, Chin Yong; Gales, Kristoffer A.; Chua, Frederic; Pena, Edgar M.; Ogden, Bryan E. (1 July 2018). "Durable engraftment of genetically modified FVIII‐secreting autologous bone marrow stromal cells in the intramedullary microenvironment". Journal of Cellular and Molecular Medicine. 22 (7): 3698–3702. doi:10.1111/jcmm.13648. ISSN 1582-1838. PMC 6010829. PMID 29682884.
  7. ^ Nirmal, Ajit J.; Regan, Tim; Shih, Barbara B.; Hume, David A.; Sims, Andrew H.; Freeman, Tom C. (28 September 2018). "Immune Cell Gene Signatures for Profiling the Microenvironment of Solid Tumors". Cancer Immunology Research. 6 (11): 1388–1400. doi:10.1158/2326-6066.CIR-18-0342. hdl:20.500.11820/e72749a6-a382-44ef-8f93-d58b3353e97c. ISSN 2326-6066. PMID 30266715.
  8. ^ Nirmal, Ajit Johnson. "Harvard Scholar Page". Harvard University.
  9. ^ Shih, Barbara B; Nirmal, Ajit J; Headon, Denis J; Akbar, Arne N; Mabbott, Neil A; Freeman, Tom C (1 April 2017). "Derivation of marker gene signatures from human skin and their use in the interpretation of the transcriptional changes associated with dermatological disorders". The Journal of Pathology. 241 (5): 600–613. doi:10.1002/path.4864. ISSN 0022-3417. PMC 5363360. PMID 28008606.

External links

  • Official website: www.ajitjohnson.com